
4-HO-MPT: Difference between revisions
>White m Text replacement - "{| |- | 17px''Main articles: Research chemicals § Toxicity and harm potential'' ''&'' ''Responsible use § Hallucinogens'' |}" to "{{further|Research chemicals#Toxicity and harm potential|Responsible use #Hallucinogens}}" |
>BronzeManul Corrected legal status in UK to being Class A in Misuse of Drugs Act 1971 and thus not covered by the Psychoactive Substances Act 2016. Corrected 'Federal Analog Act' to 'Federal Analogue Act'. Added citation needed tag to USA legality statement. |
||
Line 84: | Line 84: | ||
Due to its relative obscurity, the possession and sale of 4-HO-MPT is unscheduled in most countries. | Due to its relative obscurity, the possession and sale of 4-HO-MPT is unscheduled in most countries. | ||
*'''United Kingdom:''' | *'''United Kingdom:''' 4-HO-MPT is a Class A drug in the United Kingdom as a result of the tryptamine catch-all clause.<ref>Misuse of Drugs Act 1971 (Legislation.gov.uk) |http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I#reference-M_F_c7632653-ddad-4420-f307-e3da1e36d30e</ref> | ||
*'''United States:''' 4-HO-MPT is unscheduled in the United States. It may be considered an | *'''United States:''' 4-HO-MPT is unscheduled in the United States. It may be considered an analogue of [[psilocin]] (''4-HO-DMT'') which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical or industrial intents and purposes could be prosecuted as crimes under the Federal Analogue Act.{{citation needed}} | ||
==See also== | ==See also== |
Revision as of 23:04, 17 April 2017
4-HO-MPT | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||||||||||||||||||||
Common names | 4-HO-MPT, Meprocin | ||||||||||||||||||||||||||||||||
Substitutive name | 4-hydroxy-N-methyl-N-propyltryptamine | ||||||||||||||||||||||||||||||||
Systematic name | 3-[2-(Methylpropylamino)ethyl]-4-indolol | ||||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||||
Psychoactive class | Psychedelic | ||||||||||||||||||||||||||||||||
Chemical class | Tryptamine | ||||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||||||||
Summary sheet: 4-HO-MPT |
4-Hydroxy-N-methyl-N-propyltryptamine (also known as 4-HO-MPT) is a novel and obscure hallucinogenic psychedelic substance of the tryptamine class and can be considered to be homologous to 4-HO-DMT (i.e. Psilocin) and other hallucinogenic tryptamines with powerful psychedelic effects, yet with its own unique style variations.
Little is currently known about this substance due to its limited history of use, though it is starting to gain interest within the psychonaut community who seek out these types of experiences, being a similar but at the same time distinct variation on the mushroom or psilocin experience.[1]
Today 4-HO-MPT is either used rarely as a recreational drug or as entheogenic compound and is typically acquired through the use of online research chemical vendors on which it first appeared as recently as mid 2016.
Chemistry
4-HO-MPT, or 4-hydroxy-N,N-methylpropyltryptamine, is a synthetic indole molecule of the tryptamine class. Tryptamines share a core structure comprised of a bicylic indole heterocycle attached at R3 to an amino group via an ethyl side chain. 4-HO-MPT is substituted at R4 of its indole heterocycle with a hydroxyl functional group OH−. It also contains a propyl and ethyl chain bound to the terminal amine RN of its tryptamine backbone (MPT).
Pharmacology
Like with most psychedelic tryptamines, 4-HO-EPT is thought to act principally as a 5-HT2A partial agonist. The psychedelic effects are believed to come from 4-HO-EPT's binding efficacy at the 5-HT2A receptors. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.
Subjective effects
![]() |
This subjective effects section is a stub. As such, it is still in progress and may contain incomplete or wrong information. You can help by expanding or correcting it. |
Disclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWiki contributors. As a result, they should be viewed with a healthy degree of skepticism.
It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.
Physical effects
Cognitive effects
- Conceptual thinking
- Cognitive euphoria
- Delusions
- Emotion enhancement
- Immersion enhancement
- Increased music appreciation
- Memory suppression
- Novelty enhancement
- Personal bias suppression
- Thought loops
- Time distortion
- Unity and interconnectedness
Visual effects
Enhancements
Distortions
- Drifting (melting, breathing, morphing and flowing)
- Colour shifting
- Depth perception distortions
- Perspective distortions
- Symmetrical texture repetition
- Tracers
- After images
- Brightness alteration
- Diffraction
Hallucinatory states
- Transformations
- Internal hallucinations (autonomous entities; settings, sceneries, and landscapes; alterations in perspective and scenarios and plots)
Auditory effects
Toxicity and harm potential
The toxicity and long-term health effects of recreational 4-HO-MPT use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because 4-HO-MPT is a research chemical with very little history of human usage. Anecdotal evidence from people within the psychonaut community who have tried 4-HO-MPT suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.
It is strongly recommended that one use harm reduction practices when using this drug.
Tolerance and addiction potential
4-HO-MPT is generally considered not habit-forming and the desire to use it can actually decrease with regular consumption. Like with most psychedelics, it is most often thought to be self-regulating.
Tolerance to the effects of 4-HO-MPT are built almost immediately after ingestion. After that, it takes about 3 days for the tolerance to be reduced to half and 7 days to be back at baseline (in the absence of further consumption). 4-HO-MPT presents cross-tolerance with [[Cross-tolerance::all psychedelics]], meaning that after the consumption of 4-HO-MPT all psychedelics will have a reduced effect.
Legal issues
Due to its relative obscurity, the possession and sale of 4-HO-MPT is unscheduled in most countries.
- United Kingdom: 4-HO-MPT is a Class A drug in the United Kingdom as a result of the tryptamine catch-all clause.[2]
- United States: 4-HO-MPT is unscheduled in the United States. It may be considered an analogue of psilocin (4-HO-DMT) which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical or industrial intents and purposes could be prosecuted as crimes under the Federal Analogue Act.[citation needed]
See also
External links
References
- ↑ http://www.bluelight.org/vb/members/377522-Kaleida%7CView Profile: Kaleida | Bluelight
- ↑ Misuse of Drugs Act 1971 (Legislation.gov.uk) |http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I#reference-M_F_c7632653-ddad-4420-f307-e3da1e36d30e